References
Arroyo JF, Cohen ML. Improvement of yellow nail syndrome with oral zinc supplementation. Clin Exp Dermatol. 1993 Jan;18(1):62–4.
Avner S, Nir N et al. Combination of oral terbinafine and topical
ciclopirox compared to oral terbinafine for the treatment of
onychomycosis. J Dermatolog Treat. 2005;16(5-6):327–39.
Ayres S, Mihan R. Yellow nail syndrome: Response to vitamin E. Arch Dermatol. 1973;108:267–8.
Barel A, Colomme M et al. Effect of oral intake of
choline-stabilized orthosilicic acid on skin, nails and hair in women
with photodamaged skin. Arch Dermatol Res. 2005 Oct;297(4):147–53.
Colombo VE, Gerber F et al. Treatment of brittle fingernails and
onychoschizia with biotin: Scanning electron microscopy. J Am Acad
Dermatol. 1990 Dec;23(6 Pt 1):1127–32.
Dolan C, Hall JA et al. Photo quiz: Proximal white finger nails. Am Fam Physician. June 2004;69(12):2903–4.
Faergemann J, Baran R. Epidemiology, clinical presentation and
diagnosis of onychomycosis. Br J Dermatol. 2003 Sep;149(Suppl 65):1–4.
Farber EM, Nall J. Nail psoriasis. Cutis. 1992 Sep;50(3):174–8.
Fawcett RS, Linford S et al. Nail abnormalities: Clues to systemic disease. Am Fam Physician. 2004 Mar 15;69(6):1417–24.
Floersheim GL. Treatment of brittle fingernails with biotin. Z Hautkr. 1989;64:41–8 [in German].
Food and Drug Administration. http://www.fda.gov/cder/drug/advisory/sporanox-lamisil/qa.htm. Accessed July 10, 2006.
Fritz K. Successful local treatment of nail psoriasis with 5-fluorourocil. Z Hautkr. 1989 Dec 15;64(12):1083–8.
Gupta AK, Jain HC et al. Prevalence and epidemiology of unsuspected
onychomycosis in patients visiting dermatologists’ offices in Ontario,
Canada: A multicenter survey of 2001 patients. Int J Dermatol.
1997;36:783–7.
Gupta AK, Jain HC et al. Prevalence and epidemiology of
onychomycosis in patients visiting physicians’ offices: A multicenter
Canadian survey of 15,000 patients. J Am Acad Dermatol. 2000;43:244–8.
Gupta AK, Konnikov N et al. Prevalence and epidemiology of toenail
onychomycosis in diabetic subjects: A multicentre survey. Br J
Dermatol. 1998;139(4):665–71.
Hausmann M, Keller R. Yellow nail syndrome. Pneumologie. 1994 Jan;48(1):30–3.
Hay RJ. The future of onychomycosis therapy may involve a combination of approaches. Br J Dermatol. 2001;145(suppl 60):3–8.
Hiruma M, Matsushita A et al. One week pulse therapy with
itraconazole (200 mg day-1) for onychomycosis: Evaluation of treatment
results according to patient background. Mycoses. 2001
May;44(3-4):87–93.
Hochman LG, Scher RK et al. Brittle nails: response to daily biotin supplementation. Cutis. 1993 Apr;51(4):303-5.
Iida N, Ohsumi N. Treatment of severe deformities of the toenails by
the modified Zadik method with artificial skin. Scand J Plast Reconstr
Surg Hand Surg. 2004;38(3):155–9.
Kawada A, Aragane Y et al. Clinical and pharmacokinetic studies of
continuous itraconazole for the treatment of onychomycosis. J Dermatol.
2004 Feb;31(2):104–8.
Kyle AA, Dahl MV. Topical therapy for fungal infections. Am J Clin Dermatol. 2004;5(6):443–51.
Rigopoulos D, Katoulis AC et al. A randomized trial of amorolfine 5%
solution nail lacquer in association with itraconazole pulse therapy
compared with itraconazole alone in the treatment of Candida fingernail
onychomycosis. Br J Dermatol. 2003 Jul;149(1):151–6.
Rommel A, Havet M et al. Syndrome des ongles jaunes: Réponse à la vitamine E. Ann Dermatol Venereol. 1985;112:625–7.
Shaw J, Body R. Best evidence topic report: Incision and drainage
preferable to oral antibiotics in acute paronychial nail infection?
Emerg Med J. 2005 Nov;22(11):813–4.
Sigurgeirsson B, Olafsson JH et al. Long-term effectiveness of
treatment with terbinafine vs itraconazole in onychomycosis: A 5-year
blinded prospective follow-up study. Arch Dermatol. 2002;138:353–7.
Sikder AU, Mamun SA et al. Study of oral itraconazole and
terbinafine pulse therapy in onychomycosis. Mymensingh Med J. 2006
Jan;15(1):71–80.
Tavakkol A, Fellman S et al. Safety and efficacy of oral terbinafine
in the treatment of onychomycosis: Analysis of the elderly subgroup in
Improving Results in Onychomycosis-Concomitant Lamisil and Debridement
(IRON-CLAD), an open-label, randomized trial. Am J Geriatr
Pharmacother. 2006 Mar;4(1):1–13.
Tosti A, Piraccini BM et al. Relapses of onychomycosis after
successful treatment with systemic antifungals: A three-year follow-up.
Dermatology. 1998;197:162–6.
Williams HC, Buffham R et al. Successful use of topical vitamin E
solution in the treatment of nail changes in yellow nail syndrome. Arch
Dermatol. July 1991;127:1023–8.
Venencie PY, Dicken CH. Yellow nail syndrome: Report of five cases. J Am Acad Dermatol. 1984;10:187–92.
Zakeri M, Valikhani M et al. Topical calcipotriol therapy in nail
psoriasis: A study of 24 cases. Dermatol Online J. 2005 Dec 1;11(3):5.
Print
PDF
Email
View Health Concern
